Health professionals and consumers are advised to avoid using these products, as they contain Di-ethylene Glycol (DEG) and Ethylene Glycol (EG), which can cause serious health issues.
DRAP issues urgent recall of five contaminated syrups. The Drug Regulatory Authority of Pakistan (DRAP) has ordered an immediate recall of five syrup products contaminated with harmful chemicals, posing serious health risks to consumers.
The contamination was detected by the Directorate of Drugs Control (DDC) in Punjab and confirmed by Drug Testing Laboratories (DTLs), leading DRAP to declare these products substandard.
Contaminated Syrup Products
1. Cestonil Plus syrup (batch number 061357) by M/s Razzee Therapeutics, Lahore, Pakistan
2. Texcol DM 10mg/5ml syrup (batch number 09980) by M/s Razzee Therapeutics, Lahore
3. Speczine 5mg/5ml Syrup (batch number 280 287) by M/s Spectrum Laboratories, Lahore
4. Aphylin Syrup (batch number 24B056) by M/s Obsons Pharmaceuticals, Lahore
5. Zolint Suspension (batch number 24003) by M/s Libra (Private) Ltd, Peshawar
Health professionals and consumers are advised to avoid using these products, as they contain Di-ethylene Glycol (DEG) and Ethylene Glycol (EG), which can cause serious health issues.
This recall highlights the crucial role of regulatory oversight and testing in ensuring medication safety. Consumers are reminded to consult healthcare professionals before using any medication.
DRAP, or the Drug Regulatory Authority of Pakistan, is the governmental body responsible for regulating and ensuring the quality, safety, and efficacy of drugs and medical devices in Pakistan. Its main functions include:
- Regulation of Pharmaceuticals: DRAP oversees the registration, licensing, and monitoring of pharmaceutical products and companies. It ensures that medicines meet the required standards before they reach the market.
- Medical Device Regulation: It also regulates medical devices, ensuring that they are safe and effective for use in medical treatments.
- Drug Quality Control: The authority conducts inspections and tests to ensure that drugs manufactured and imported into Pakistan adhere to established quality standards.
- Policy and Guidelines Development: DRAP formulates policies, guidelines, and regulations related to drug approval, manufacturing, and distribution.
- Public Health Safety: It monitors adverse drug reactions and takes necessary actions to protect public health.
- Enforcement and Compliance: DRAP enforces laws related to drug manufacturing and sales, and it ensures compliance with national and international regulations.
The agency plays a crucial role in the healthcare system by ensuring that the medicines and medical devices available to the public are safe, effective, and of high quality.
